Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection.
about
Successful cognitive aging and health-related quality of life in younger and older adults infected with HIVRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersHIV and antiretroviral therapy in the brain: neuronal injury and repairEvidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective casesNeurotrophins modulate the expression of chemokine receptors in the brain.Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Neuroprotective strategies for HIV-1 associated dementia.Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.The shifting patterns of HIV encephalitis neuropathology.Molecular and cellular mechanisms of neuronal cell death in HIV dementia.Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning.Chemokine receptors and neurotrophic factors: potential therapy against aids dementia?Growth-associated protein-43 and ephrin B3 induction in the brain of adult SIV-infected rhesus macaques.Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.Molecular pathology of neuro-AIDS (CNS-HIV).Construction of a recombinant human FGF1 expression vector for mammary gland-specific expression in human breast cancer cells.Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis.Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons.
P2860
Q27000425-31B38DB0-AB94-43B9-B272-646A20F44560Q27025573-DD7DE6AB-EE83-4526-85C3-D389A2DC4C2FQ28279808-2F331125-F74A-41E6-9C1B-F0A5472D46E9Q33570376-83641D81-14DB-40DB-84A1-8B61C3CA664FQ34802758-5A25FF1F-F581-4A26-AAFD-589470DAC55AQ34995472-16EAE88C-6A3C-42D9-A6DB-8C7518E3D0F3Q35177355-49202692-A203-4612-9024-5959821CEC97Q36003825-BA1BF0B8-B2A5-488B-B612-35DF675147F4Q36302045-54C9F9E1-0C9C-4E52-A667-2CB496D4DBCEQ36302049-ECF5F643-D40C-4890-8B27-D6C443A92DE6Q36302067-64D19AE7-64D9-4D0F-AA9C-43DADCA07B69Q36872842-35A81606-A9DD-4523-A1F2-3BC1C97563A9Q36936954-6A3E222C-5007-48DC-82C6-6A5DE80A6C98Q37184140-08A928B0-B1EC-45D0-96E1-5E0190765B80Q37351271-C438DD4A-175C-4849-8F2A-7EBFFD364976Q37462244-684C9448-B321-42B5-B4DD-5E4768DEEB46Q39565125-CE96CBCE-5968-4D73-97DA-6FC928EDCF3DQ40016826-0458069C-DCAE-44F2-99FD-A9C6F7C411C2Q40754408-77FC96BA-3548-4D6A-A734-E271E91BF3D9Q41815732-0BBC630A-C0EB-4123-8A12-045E905BD78D
P2860
Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Amelioration of neurotoxic eff ...... strategy for neuroprotection.
@en
Amelioration of neurotoxic eff ...... strategy for neuroprotection.
@nl
type
label
Amelioration of neurotoxic eff ...... strategy for neuroprotection.
@en
Amelioration of neurotoxic eff ...... strategy for neuroprotection.
@nl
prefLabel
Amelioration of neurotoxic eff ...... strategy for neuroprotection.
@en
Amelioration of neurotoxic eff ...... strategy for neuroprotection.
@nl
P2093
P2860
P356
P1476
Amelioration of neurotoxic eff ...... strategy for neuroprotection.
@en
P2093
P2860
P304
P356
10.1093/JNEN/60.3.293
P577
2001-03-01T00:00:00Z